MedPath

VERSA VASCULAR INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

A First in Human Study for the Versa Device for Tricuspid Regurgitation

Not Applicable
Active, not recruiting
Conditions
Tricuspid Regurgitation
Interventions
Device: Versa Implant
First Posted Date
2024-04-16
Last Posted Date
2024-12-05
Lead Sponsor
Versa Vascular, Inc
Target Recruit Count
10
Registration Number
NCT06368401
Locations
🇨🇱

Pontificia Universidad Católica, Santiago, Chile

🇳🇿

Auckland City Hospital, Auckland, New Zealand

© Copyright 2025. All Rights Reserved by MedPath